Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid

about

Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid

Item

http://www.wikidata.org/entity/Q58754930

description

scientific article published on 01 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Interaction of immunosuppressa ...... effects with mycophenolic acid

@en

Interaction of immunosuppressa ...... effects with mycophenolic acid

@nl

type

Item

label

Interaction of immunosuppressa ...... effects with mycophenolic acid

@en

Interaction of immunosuppressa ...... effects with mycophenolic acid

@nl

prefLabel

Interaction of immunosuppressa ...... effects with mycophenolic acid

@en

Interaction of immunosuppressa ...... effects with mycophenolic acid

@nl

P1476

Interaction of immunosuppressa ...... effects with mycophenolic acid

@en

P2093

Herold J Metselaar

http://www.w3.org/2001/XMLSchema#string

Jan Nm Ijzermans

http://www.w3.org/2001/XMLSchema#string

Petra E de Ruiter

http://www.w3.org/2001/XMLSchema#string

Robert J de Knegt

http://www.w3.org/2001/XMLSchema#string

Yashna Gadjradj

http://www.w3.org/2001/XMLSchema#string

P2860

A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection

Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes

Mycophenolic acid, an immunomodulator, has potent and broad-spectrum in vitro antiviral activity against pandemic, seasonal and avian influenza viruses affecting humans.

Correlation between dose and level of cyclosporine after orthotopic liver transplantation.

Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA.

Discovery of daclatasvir, a pan-genotypic hepatitis C virus NS5A replication complex inhibitor with potent clinical effect.

An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects

Immunosuppression: towards a logical approach in liver transplantation.

P304

156-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5500/WJT.V8.I5.156

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luc J.W. van der Laan

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30211024

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

P932

6134272

http://www.w3.org/2001/XMLSchema#string